78 FIRST-LINE MODIFIED SCHEDULE OF GEMCITABINE INDUCES HIGH CLINICAL BENEFIT RATE WITHOUT SIGNIFICANT TOXICITY IN ELDERLY OR NOT ELDERLY ECOG PS 2 PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER

✍ Scribed by A. Nacci; E. Mazzoni; P. Rizzo; L. Orlando; F. Sponziello; N. Calvani; P. Schiavone; M. D'Amico; A. Marino; P. Fedele; M.C. Chetri; M. Cinefra; S. Cinieri

• Book ID: 117487978
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 265 KB
• Volume: 36
• Category: Article
• ISSN: 0305-7372
• DOI: 10.1016/s0305-7372(10)70104-3